Prophylaxis and treatment of venous thromboembolism in patients with cancer: an update
β Scribed by Michela Falciani; Davide Imberti; Domenico Prisco
- Publisher
- Springer Milan
- Year
- 2006
- Tongue
- English
- Weight
- 79 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1828-0447
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Venous thromboembolism (VTE) is common but often unrecognized in medically ill patients. Over the past 5 years, three large-scale placebo-controlled trials enrolling a total of 5500 medically ill patients have highlighted the risk of VTE in this group. These trials have helped to define a specific a
## Abstract ## BACKGROUND. The authors compared the relative efficacy and safety of lowβ molecularβweight heparin (LMWH) and unfractionated heparin (UFH) for the initial treatment of venous thromboembolism (VTE) between patients with and without cancer. ## METHODS. By using Cochrane methodology